Glycoproteomic Research Opportunity – Call For Proposals

InterVenn, the leader in the application of glycoproteomics to biomarker discovery, is announcing a Request for Proposals whereby:

• The investigator has identified a clinical oncology application where the discovery and use of liquid-biopsy-based biomarkers that enable disease diagnosis, prognosis, or therapy response prediction and monitoring will significantly improve patient care; and
• The investigator will provide
• • de-identified patient serum samples (100 µl each, stored at -80°C) and
  • respective de-identified demographic and clinical data to address the question of interest.

During the 2021 American Association for Cancer Research (AACR) Conference, InterVenn will announce the selected proposals.

For the selected proposals, InterVenn will:

• Carry out quantitative glycoproteomic analysis of a panel of ≈100 plasma glycoproteins / ≈800 glycopeptides;
• Provide support for logistics, sample processing and analysis;
• Share data and results of statistical and bioinformatic analysis.

Please submit through the online request form or complete the provided template describing the project, its significance and rationale, and the patient sample/data resources that will be used, and send to 2021rfp@venn.bio by Friday, March 27, 2021.

We thank you for your interest and look forward to reviewing your proposal.

Sincerely,
Klaus Lindpaintner, M.D., MPH
Chief Scientific and Medical Officer